During July 26-28, the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo was held in McCormick Place Convention Center in Chicago. Departed by the sprawling virus for two years, Wondfo is elated to have your visit of Wondfo’s booth during AACC and to have your long-standing support for Wondfo.
Impressive Single-Dose Reagent Cartridge Design—Accre CLIA System
Since the product launch of Accre CLIA System
in early 2022, Accre Family
has been exhibited in several international Expos and has been widely appreciated. During AACC 2022, the exhibited Accre 8 and Accre 90 have gained wide appreciation for the cutting-edge innovation of single-dose reagent cartridge. The all-in-one design enables the integration of excellence of Chemiluminescence Immunoassay and the flexibility of Point-of-Care Testing. What’s more, the excellence goes beyond methodology and cutting-edge design of single-dose cartridge, enjoying exquisite outlook design.
Integrated Molecular Solution—U-Card Dx™ Automated Rapid Molecular Diagnostic Instrument
Wondfo has been devoted to realize “Sample In, Result Out” with constant research and development. Wondfo’s automated molecular diagnostic instrument—U-Card Dx™
integrates lysis, amplification and result analysis, accurately controls temperature, valves and volume and so to maximize accuracy and integration, realizing one lab in one cartridge with one-step operation. The lyophilized reagent allows easy transportation and storage. With compact cartridge, one-step operation, short turnaround time and flexible storage, U-Card Dx™ PoC Molecular Diagnostic Instrument is a good fit for small- and middle-size labs. We are glad to have many visitors expressing their willingness to cooperate with us.
Veterinary Solution & DOA Detection & Fertility Tests from Wondfo USA Subsidiary
AACC 2022 witnesses the Veterinary Solution, DOA solution and fertility solution from Wondfo USA Subsidiary. With newly launched Accre 6 being included, veterinary solution provides comprehensive detection of chemiluminescence immunoassay, fluorescence immunoassay, dry biochemistry and coagulation. User-friendly interface and simplified operation reduce the burden on healthcare providers.
Constant Innovation and Devotion to Research
As Wondfo’s two founders are both professors from university, we attach great significance to R&D, with 10% of annual revenue being invested in R&D. Professor Wang Jihua, President of Wondfo was among the Wondfo team in the Expo. We have regarded it as our mission to offer improved testing solution of cutting-edge technologies for various scenarios, to assist in disease control and prevention, and to safeguard people’s health and happiness.
As 2022 marks the 30th anniversary of Wondfo, we are honored to have your precious trust and warm support in the last 3 decades, and we are willing to keep Racing for Life.